Literature DB >> 2814776

Long-term endoscopic injection sclerotherapy of bleeding esophageal varices. A prospective analysis of results by endoscopy, manometry and 24-h pH-monitoring.

F Siemens1, K J Paquet, P Koussouris, M A Mercado, J F Kalk.   

Abstract

From 1 January 1986 to 1 January 1988, 91 consecutive patients who had undergone repeated paravariceal endoscopic injection sclerotherapy (PEIS) for bleeding esophageal varices over a period of up to 10 years were followed up prospectively by endoscopy, manometry and 24-h pH monitoring. In 39% nonfatal complications occurred after two phases of PEIS. The number of complications tended to decrease with increasing phases and was only 12% after five or more phases of PEIS. Endoscopy is undoubtedly the most important method in the follow-up of these patients. Early and long-term complications are mostly diagnosed by direct view and thus can be managed or sometimes even prevented in the follow-up. No significant motility disorders were found. Only 12 patients showed significant gastroesophageal reflux. No correlation was found between the severity of reflux and the number of phases of PEIS. No correlation between clinical symptoms and changes in the manometric and pH metric results could be found. The effects and side effects of PEIS can be closely monitored by manometry and pH monitoring and therapy can be tailored accordingly. Our results suggest that PEIS is a superb method with a low complication rate, both short- and long-term. It has proven to be an effective long-term treatment of bleeding esophageal varices.

Entities:  

Mesh:

Year:  1989        PMID: 2814776     DOI: 10.1007/BF00591359

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  16 in total

1.  Esophageal acid-clearance and motility after endoscopic sclerotherapy of esophageal varices.

Authors:  H Snady; M A Korsten
Journal:  Am J Gastroenterol       Date:  1986-06       Impact factor: 10.864

2.  Effects of repeated injection sclerotherapy on acid gastroesophageal reflux.

Authors:  T Sauerbruch; R Wirsching; J Holl; J Gröbl; M Weinzierl
Journal:  Gastrointest Endosc       Date:  1986-04       Impact factor: 9.427

3.  Oesophageal function in cirrhotic patients undergoing injection sclerotherapy for oesophageal varices.

Authors:  S J Ogle; C J Kirk; R J Bailey; A G Johnson; R Williams; I M Murray-Lyon
Journal:  Digestion       Date:  1978       Impact factor: 3.216

4.  Immediate endoscopic sclerosis of bleeding esophageal varices. A prospective evaluation over five years.

Authors:  K J Paquet; J F Kalk; P Koussouris
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

5.  Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial.

Authors:  B R MacDougall; D Westaby; A Theodossi; J L Dawson; R Williams
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

6.  Esophageal motility: effects of injection sclerotherapy.

Authors:  G M Larson; D J Vandertoll; D T Netscher; H C Polk
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

7.  Technique, indications, and clinical use of 24 hour esophageal pH monitoring.

Authors:  T R DeMeester; C I Wang; J A Wernly; C A Pellegrini; A G Little; P Klementschitsch; G Bermudez; L F Johnson; D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1980-05       Impact factor: 5.209

8.  Esophageal function after injection sclerotherapy: pathogenesis of esophageal stricture.

Authors:  J J Reilly; R R Schade; D S Van Thiel
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

9.  Esophageal motility and symptoms after endoscopic injection sclerotherapy.

Authors:  L B Cohen; C Simon; M A Korsten; E J Scherl; J Skorniky; M B Guelrud; J D Waye
Journal:  Dig Dis Sci       Date:  1985-01       Impact factor: 3.199

10.  Sclerotherapy of bleeding oesophageal varices by means of endoscopy.

Authors:  K J Paquet; E Oberhammer
Journal:  Endoscopy       Date:  1978-02       Impact factor: 10.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.